French biotech to step up clinical development of ABX464.
Trial involves generics supplied by Mylan.
Vosevi is aimed at tough to treat patients.
Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.
The service will provide a live helpdesk for expectant mothers.
Decision branded “shameful” by HIV campaigners.